The US Food and Drug Administration (FDA) has found nine deviations in Indian drug maker Cipla’s manufacturing process during a recent inspection of the company’s Bangalore plant. The Mumbai-based company, however, said the deviations are minor ones relating to manufacturing practices.

Sun Pharmaceutical Industries Ltd. on Monday announced that the US Food & Drug Administration (FDA) has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market Roxicodone, oxycodone hydrochloride tablets.

Sun Pharmaceutical Industries Ltd. (524715.BY) has received U.S. Food & Drug Administration approval to make and sell generic versions of anticonvulsant topiramate tablets.

The US Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company announced. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD).